ArticleCommunications medicine2022

Retrospective study of the immunogenicity and safety of the CoronaVac SARS-CoV-2 vaccine in people with underlying medical conditions.

Chunmei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.